Lv1
70 积分 2023-01-10 加入
Platelet-Derived TGF-β1 Induces Functional Reprogramming of Myeloid-Derived Suppressor Cells in Immune Thrombocytopenia
22天前
已完结
Platelet-Derived TGF-β1 Induces Functional Reprogramming of Myeloid-Derived Suppressor Cells in Immune Thrombocytopenia
22天前
已关闭
504 CS2009, a novel first-in-class trispecific antibody targeting PD-1, CTLA-4, and VEGFa, demonstrates promising anti-tumor activity in preclinical evaluation
1个月前
已完结
Dinaciclib induces immunogenic cell death and enhances anti-PD1–mediated tumor suppression
4个月前
已完结
Achievable but elusive: LLDAS and DORIS remission in clinical trials of belimumab
4个月前
已完结
BCMA-Targeted T-Cell–Engager Therapy for Autoimmune Disease
4个月前
已完结
A Phase 1 Study of PIT565, a First-in-Class, Anti-CD3, Anti-CD19, Anti-CD2 Trispecific Antibody in Patients with Relapsed and/or Refractory B-Cell Malignancies
4个月前
已关闭
A Phase 1 Study of PIT565, a First-in-Class, Anti-CD3, Anti-CD19, Anti-CD2 Trispecific Antibody in Patients with Relapsed and/or Refractory B-Cell Malignancies
4个月前
已关闭
Peptide-drug conjugates: A new paradigm for targeted cancer therapy
4个月前
已完结
PIT565, a First-in-Class Anti-CD19, Anti-CD3, Anti-CD2 Trispecific Antibody for the Treatment of B Cell Malignancies
4个月前
已关闭
皖公网安备34019202002308
